Liver cancer is one of the most serious and life-threatening cancers worldwide. According to the International Agency for Research on Cancer (IARC), liver cancer remains one of the leading causes of cancer-related deaths globally. As…
RNA therapeutics for cardiovascular disease are emerging as a transformative strategy for long-term disease management. Unlike traditional treatments that target proteins after they are produced, RNA-based therapies such as siRNA and antisense oligonucleotides act at…
Over the past two decades, the China API industry has evolved into a foundational pillar of the global pharmaceutical ecosystem. 🌏 HongKong DengYue Medicine continues to track global demand shifts in the china api industry…
The excitement surrounding antibody-drug conjugates (ADCs) has not yet faded, but a new frontier is already capturing the attention of global pharmaceutical giants. 🔥 Recently, Johnson & Johnson announced a $1 billion acquisition of Firefly…
More and more overseas patients are beginning to explore China’s innovative drug resources in search of new treatment opportunities. However, for international patients, the real challenge is often not whether the medicines exist, but rather:…
From precision medicine to immunotherapy, from novel targeted drugs to cell therapy, China has formed unique strengths in several cancer treatment fields. As a platform connecting international patients with China’s medical resources, DengYueMed closely follows…
In today’s increasingly complex pharmaceutical distribution system and highly active cross-border trade environment, counterfeit medicines have evolved from a national regulatory issue into a global public health and supply chain challenge. Both developed and developing…
As Semaglutide, Tirzepatide, and next-generation multi-target peptides like Retatrutide advance in development and commercialization, China’s peptide API industry is entering a new capacity expansion cycle. Currently, the China peptide API company landscape has gradually formed…
In the global pharmaceutical supply chain, drug transportation is no longer a simple logistics process. It has evolved into a highly specialized system focused on pharmaceutical stability management. Different dosage forms exhibit major differences in…
Spinal muscular atrophy (SMA) has seen continuous advances in spinal muscular atrophy research, clinical treatment, and long-term disease management in recent years. With the expanding use of disease-modifying therapies (DMTs) and the growing accumulation of…
Key Takeaways Understand the overall system: Modern cancer treatment in China has developed into a multidisciplinary, tiered system covering surgery, radiotherapy, systemic therapy, immunotherapy, and interventional procedures, while increasingly integrating precision medicine and emerging biologic…
A cancer diagnosis often brings many important questions.Which treatment option is most suitable? Which hospital has the right expertise? Should patients consider seeking further treatment overseas? In recent years, China has become an increasingly important…
